Preferred Label : propranolol hydrochloride;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 318-98-9; F8A3652H1V;
Codes EINECS : 206-268-7;
Is substance : O;
UNII : F8A3652H1V;
InChIKey : ZMRUPTIKESYGQW-UHFFFAOYSA-N;
Origin ID : M0017776;
UMLS CUI : C0282321;
CISMeF manual mappings
- Related record
- Semantic type(s)
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol
---
https://www.has-sante.fr/jcms/p_3195779/fr/hemangiol
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
propranolol hydrochloride
administration, oral
adrenergic beta-antagonists
propranolol
infant, newborn
infant
hemangioma, capillary
propranolol
---
https://www.has-sante.fr/jcms/p_3117103/fr/propranolol-arrow
2019
false
false
false
France
propranolol hydrochloride
propranolol
angina pectoris
hypertension
myocardial infarction
cardiomyopathy, hypertrophic
arrhythmias, cardiac
hyperthyroidism
thyrotoxicosis
migraine disorders
Esophageal Varices Hemorrhage
essential tremor
treatment outcome
insurance, health, reimbursement
drugs, generic
administration, oral
evaluation of the transparency committee
propranolol
---
http://www.has-sante.fr/portail/jcms/c_1753945/fr/hemangiol
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
pharmaceutical solutions
propranolol
propranolol
propranolol hydrochloride
propranolol hydrochloride
insurance, health, reimbursement
treatment outcome
infant
hemangioma
infant, newborn, diseases
clinical trials as topic
other dermatologicals
guidelines for drug use
---
http://www.has-sante.fr/portail/jcms/c_1648984/fr/propranolol-ratiopharm
http://www.has-sante.fr/portail/jcms/c_1648983/fr/propranolol-ratiopharm-04092013-avis-ct13159
http://www.has-sante.fr/portail/display.jsp?id=c_603162
2013
France
French
antimigraine preparations
Cardiotoxicity
evaluation of the transparency committee
propranolol
Delayed-Action preparations
propranolol hydrochloride
propranolol
administration, oral
insurance, health, reimbursement
adrenergic beta-antagonists
antihypertensive agents
anti-arrhythmia agents
-
-
hypertension
angina pectoris
myocardial infarction
arrhythmias, cardiac
cardiomyopathy, hypertrophic
migraine disorders
esophageal and gastric varices
gastrointestinal hemorrhage
hyperthyroidism
thyroid hormones
heart diseases
---
